The most comprehensive and patient-centric Tumor Profiling Services that enables improved cancer patient management, treatment, and monitoring. Dante Labs brings together Precision Oncology and Next-Generation Sequencing to directly benefit cancer patients
Comprehensive end-to-end solutions for oncologists, patients and clinical researchers
Wide array of tests for cancer patients. Solid Tumor Sequencing and Cell Free Circulating Tumor DNA from Liquid Biopsies.
Smart interpretation for actionable reports.
Precision Oncology powered by Next-Generation Sequencing
Whole Genome and Whole Exome Sequencing Tests and Broad Pan-cancer Targeted Sequencing Panels enable oncologists to effectively run hundreds of diagnostics tests in parallel through one assay.
Results in days and weeks, not months.
AI-powered software platform, data-driven treatment decisions
Oncologists will be able to sift through the vast amounts of data produced from these tests and view approved therapies and clinical trials most appropriate for their patient, empowering oncologists to make smarter treatment decisions
Complete Tumor Profiling
We drive the oncology field towards true precision oncology and enable advanced NGS analytics for Germline and Somatic testing
Solid Tumor Biopsies, Cell Free Circulating Tumor DNA from Liquid Biopsies, Whole Genome and Whole Exome Sequencing
The combined solutions will enable oncologists to precisely and comprehensively profile a patient’s tumor and ultimately improve outcomes